BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Jun 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-05-31

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-31	Common Stock	M	3800	$11.74	Acquired	41951	Direct
2011-05-31	Common Stock	S	3800	$28.50	Disposed	38151	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-05-31	Stock Option (right to buy)	$11.74	M	3800	Disposed	2016-01-05	Common Stock (3800)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading Plan, executed March 14, 2011.

F2: Original option grant vested 6/48ths on July 6, 2006 and 1/48th on the 6th day of every month thereafter.